Telormedix
Via della Posta 10
Bioggio
CH-6934
Website: http://www.telormedix.com/
Email: telormedix@telormedix.com
18 articles about Telormedix
-
Telormedix Granted European Patent For Vesimune
9/22/2014
-
Telormedix' Vesimune Successfully Completes Phase 2 For Carcinoma In Situ Of The Bladder
5/16/2014
-
Telormedix Raises $6.6 Million In Series B Financing Round
12/2/2013
-
Molecular Profiles Selected to Develop Topical & Oral Psoriasis Products for Telormedix
9/23/2013
-
Telormedix Receives EU Funding for the Development of a New Treatment for Psoriasis
8/7/2013
-
Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment
6/4/2012
-
Telormedix and SUPSI Receive Funding from CTI/KTI for Research Collaboration on Molecular Modeling of Drug-Target Interactions
3/6/2012
-
Telormedix Elected Member of TIMER Collaborative Research Program
1/31/2012
-
Telormedix Secures Further Funding With $7.5 Million CHF
1/10/2012
-
Telormedix Announces Promising TMX-202 Preclinical Results for Skin Cancer Treatment
10/31/2011
-
Telormedix Receives EU Funding to Coordinate the Development of Innovative Liposomes for Adjuvant and Vaccine Delivery
9/6/2011
-
Telormedix Appoints Nick Rogerson as New Chairman of the Board
8/2/2011
-
Telormedix and Swiss TPH Institute Sign Malaria and Buruli Ulcer Collaboration
8/3/2010
-
Telormedix TMX-101 Commences Clinical Trial for Bladder Cancer
6/14/2010
-
Telormedix Appoints Phillipe Lutz Chief Financial Officer
5/4/2010
-
Telormedix Announces Launch of New Website
11/3/2009
-
Telormedix Appoints Johanna Holldack as CEO
10/27/2009
-
Telormedix Raises $19 Million in Series A Financing
9/30/2008